{
    "Trade/Device Name(s)": [
        "GlucoDr\u2122M auto Blood Glucose Monitoring System",
        "GlucoDr\u2122 auto Blood Glucose Monitoring System"
    ],
    "Submitter Information": "All Medicus Co., Ltd.",
    "510(k) Number": "K083628",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043474"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFR",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "April 28, 2009",
    "Summary Letter Received Date": "April 28, 2009",
    "Submission Date": "November, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Arterial whole blood",
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GlucoDr\u2122M auto Test Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Measurement of electrical currents by reaction of glucose with reagents on electrode strip"
    ],
    "Submission Type(s)": [
        "System",
        "Test Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for GlucoDr\u2122M auto Blood Glucose Monitoring System for quantitative measurement of glucose in whole blood by electrochemical detection",
    "Indications for Use Summary": "Intended for in vitro quantitative measurement of glucose in venous, arterial and capillary whole blood at various body sites for monitoring effectiveness of diabetes control, not for diagnosis or screening nor use on neonates",
    "fda_folder": "Clinical Chemistry"
}